BIOCRYST PHARMACEUTICA
7,7650
08-ноября-24 14:29:57
15 мин. задержка
Акции
+0,0950
+1,24%
Сегодняшний диапазон
7,5200 - 7,8400
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
05 апр 2024 08:45:07 Источник NetDania Notify
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
04 апр 2024 14:51:53 Источник NetDania Notify
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
03 апр 2024 08:45:12 Источник NetDania Notify
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 апр 2024 06:00:23 Источник Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
02 апр 2024 11:00:22 Источник NetDania Notify
-
BioCryst to Present at Upcoming Investor Conferences
25 мар 2024 15:01:00 Источник Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
14 мар 2024 12:48:51 Источник NetDania Notify
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 мар 2024 06:01:47 Источник Nasdaq GlobeNewswire
-
BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones
26 фев 2024 06:00:05 Источник Nasdaq GlobeNewswire
-
23 фев 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
21 фев 2024 15:01:58 Источник Nasdaq GlobeNewswire
-
BioCryst Launches ORLADEYO® (berotralstat) in Italy
19 фев 2024 06:54:52 Источник Nasdaq GlobeNewswire
-
BioCryst to Report Fourth Quarter 2023 Financial Results on February 26
12 фев 2024 06:00:53 Источник Nasdaq GlobeNewswire
-
05 фев 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 фев 2024 06:00:48 Источник Nasdaq GlobeNewswire
-
05 янв 2024 15:01:00 Источник Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 янв 2024 15:01:59 Источник Nasdaq GlobeNewswire
-
BioCryst to Present at 42nd Annual J.P. Morgan Healthcare Conference
03 янв 2024 06:00:50 Источник Nasdaq GlobeNewswire
-
19 дек 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 дек 2023 15:01:42 Источник Nasdaq GlobeNewswire